Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Medicinova (MNOV)
NASDAQ:MNOV
Medicinova (MNOV) Stock Price & Analysis
280 Followers
MNOV Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.26 - $2.66
Previous Close$1.54
Volume17.02K
Average Volume (3M)51.31K
Market Cap
$75.53M
Enterprise Value$24.75M
Total Cash (Recent Filing)$51.00M
Total Debt (Recent Filing)$215.93K
Price to Earnings (P/E)-8.8
Beta0.44
Next Earnings
Apr 26, 2023EPS Estimate
-$0.07Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.17
Shares Outstanding49,046,246
10 Day Avg. Volume46,826
30 Day Avg. Volume51,313
Standard Deviation0.12
R-Squared0.11
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)1.46
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-38.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue24.75
Enterprise Value/Gross Profit24.75
Enterprise Value/Ebitda-2.00
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Medicinova News
Ownership Overview
71.66%
Insiders
2.56% Mutual Funds
4.12% Other Institutional Investors
21.67% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
MNOV FAQ
What was Medicinova’s price range in the past 12 months?
Medicinova lowest stock price was $1.26 and its highest was $2.66 in the past 12 months.
What is Medicinova’s market cap?
Currently, no data Available
When is Medicinova’s upcoming earnings report date?
Medicinova’s upcoming earnings report date is Apr 26, 2023 which is 358 days ago.
How were Medicinova’s earnings last quarter?
Medicinova released its earnings results on Jul 27, 2022. The company reported -$0.15 earnings per share for the quarter, missing the consensus estimate of -$0.087 by -$0.063.
Is Medicinova overvalued?
According to Wall Street analysts Medicinova’s price is currently Overvalued.
Does Medicinova pay dividends?
Medicinova does not currently pay dividends.
What is Medicinova’s EPS estimate?
Medicinova’s EPS estimate is -$0.07.
How many shares outstanding does Medicinova have?
Medicinova has 49,046,246 shares outstanding.
What happened to Medicinova’s price movement after its last earnings report?
Medicinova reported an EPS of -$0.15 in its last earnings report, missing expectations of -$0.087. Following the earnings report the stock price went down -1.835%.
Which hedge fund is a major shareholder of Medicinova?
Among the largest hedge funds holding Medicinova’s share is Caxton Associates LP. It holds Medicinova’s shares valued at N/A.
---
Medicinova Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-33.04%
12-Months-Change
Fundamentals
Return on Equity
-12.93%
Trailing 12-Months
Asset Growth
-10.63%
Trailing 12-Months
Company Description
Medicinova
MediciNova, Inc. is a biopharmaceutical company, which engages in the acquisition and development of small molecule therapeutics for the treatment of serious diseases for the treatment of diseases with unmet medical need. Its development pipeline consists of clinical-stage compounds for the treatment of acute exacerbations of asthma and COPD, progressive multiple sclerosis, methamphetamine addiction, neuropathic pain, asthma, interstitial cystitis, and solid tumor cancers. The company was founded by Yuichi Iwaki on September 26, 2000 and is headquartered in La Jolla, CA.
---
Technical Analysis
---